Mother-Infant Dyad & Integrated SUD Care
Deep Dive Materials
About This Enrichment Document: This companion to the clinical guide provides extended references, detailed case analyses, implementation tools, policy considerations, and emerging research updates for clinicians seeking deeper expertise in perinatal SUD care.
Extended References & Evidence Base
Primary Studies
Retrospective cohort of 127 pregnant individuals with OUD. Co-located OB-Addiction care reduced preterm birth from 26.6% to 11.8% (p<0.01) and increased treatment retention to 94% vs 67% in fragmented care (p<0.001).
2. ESC-NOW Trial (NIH/NICHD, 2023)
Multicenter RCT (n=1,305) demonstrated 6.7-day reduction in length of stay and 63% reduction in pharmacotherapy with Eat, Sleep, Console vs Finnegan-based care. Cost savings: $12,400 per infant.
3. Missouri PQC SUD Bundle (2019-2024)
Statewide quality collaborative implementing AIM bundle across 67 birthing hospitals. Screening rates increased 47.9% (to 99%), maternal safe plans increased 144.4% (to 90.5%).
Guidelines & Frameworks
- SAMHSA Clinical Guidance (SMA 18-5054) — 16 factsheets covering prenatal through infant care
- AIM CPPPSUD Patient Safety Bundle — 5 R's framework with implementation toolkit
- SOAP Consensus Statement on Pain Management for Pregnant Patients with OUD
- AAP Policy: Substance Use During Pregnancy and Plans of Safe Care
- ACOG Committee Opinion 711: Opioid Use and Opioid Use Disorder in Pregnancy
Detailed Case Studies for Teaching
Case 1: Complex Trauma and OUD
Patient: 24-year-old G1P0 at 18 weeks, history of childhood sexual abuse, current intimate partner violence, daily heroin use. Presents to ED with withdrawal.
Clinical Decisions:
- Initiated buprenorphine 8mg BID using "low and slow" approach given trauma sensitivity
- Immediate IPV safety planning and shelter referral
- PTSD-informed care: avoided retraumatization, allowed support person during exams
- Plan of Safe Care developed with CPS liaison before any CPS notification
Outcome: Continued buprenorphine through delivery. Infant with mild NOWS managed non-pharmacologically. Patient engaged in trauma therapy, obtained restraining order, transitioned to safe housing.
Teaching Points: Trauma-informed care is not optional—it's essential for engagement. IPV and SUD often co-occur; address safety first. CPS collaboration can be supportive, not adversarial.
Case 2: Late Presentation and Rapid Engagement
Patient: 32-year-old G3P2 at 36 weeks, no prenatal care, arrives in active labor with opioid withdrawal.
Clinical Decisions:
- Immediate methadone initiation per hospital protocol (20mg initial dose)
- Anesthesia consult for multimodal pain management
- Pediatric team alerted for NOWS monitoring using ESC approach
- 48-hour stay with intensive social work intervention
Outcome: Delivered at 37 weeks. Infant with moderate NOWS, managed with oral morphine wean over 7 days. Mother linked to outpatient OTP with weekly follow-up.
Teaching Points: Late engagement is common—don't judge. Emergency MOUD initiation is safe and effective. The 48-72 hour post-birth window is critical for establishing outpatient linkage.
Implementation Tools
1. Plan of Safe Care Template
| Domain | Assessment Questions | Action Items |
|---|---|---|
| Maternal Health | MOUD provider? OB follow-up scheduled? Mental health needs? | List providers, dates, contact info |
| Infant Health | Pediatrician identified? NOWS risk level? Early intervention referral? | Pediatric appointment, feeding plan |
| Safety | Safe sleep plan? Housing stability? IPV screening? | Sleep education, shelter if needed |
| Social Support | Family support? Recovery community? WIC enrollment? | Peer specialist, support group |
2. Warm Handoff Checklist
- ☐ Outpatient MOUD appointment scheduled within 7 days
- ☐ Direct provider-to-provider phone call completed
- ☐ Discharge summary sent within 48 hours
- ☐ Medication supply sufficient until appointment
- ☐ Naloxone kit provided with education
- ☐ Peer recovery specialist contacted patient
- ☐ Plan of Safe Care shared with all providers
- ☐ Transportation needs addressed
3. Non-Stigmatizing Language Guide
| Instead of... | Use... |
|---|---|
| Addict, abuser, junkie | Person with OUD, person in recovery |
| Clean/dirty urine | Urine toxicology consistent with prescribed medications; substance detected |
| The addict in Room 3 | Patient with OUD in Room 3 |
| Non-compliant | Challenges with adherence, barriers to care |
| Failed treatment | Relapse, return to use |
Policy Considerations
CAPTA/CARA Requirements
State-by-State Variation
- Punitive states: Substance use in pregnancy = child abuse/neglect under state law (20+ states)
- Non-punitive states: Focus on Plans of Safe Care, voluntary services (10 states)
- Mixed approaches: Notification required but not automatic removal
Advocacy Opportunities
- Hospital-based Plan of Safe Care protocols that emphasize treatment engagement
- Medical-legal partnerships to address custody barriers to treatment
- State perinatal quality collaboratives to standardize non-punitive approaches
Emerging Research Updates
Tele-MOUD in Pregnancy
Recent studies (2023-2024) demonstrate equivalent outcomes for telehealth-initiated buprenorphine vs in-person care in pregnancy. Key considerations:
- Appropriate for patients with stable housing and reliable technology
- Requires local lab partnership for urine toxicology
- May reduce barriers for rural patients
Extended-Release Buprenorphine
Monthly injectable buprenorphine (Sublocade) is increasingly used in pregnancy. Limited but growing evidence suggests safety and efficacy. Consider for patients with:
- History of medication non-adherence
- Transportation barriers to daily/weekly dosing
- Preference for long-acting formulation
NOWS Prediction Models
Machine learning algorithms using maternal factors (MOUD type/dose, polysubstance use) show promise for predicting NOWS severity. Not yet validated for clinical decision-making but may guide resource allocation.
Additional Resources
- American College of Obstetricians and Gynecologists (ACOG): Substance Use and Pregnancy resources
- Substance Abuse and Mental Health Services Administration (SAMHSA): Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder
- Alliance for Innovation on Maternal Health (AIM): Patient Safety Bundles
- National Center on Substance Abuse and Child Welfare (NCSACW): Plans of Safe Care resources